Its mission is to contribute to global health by strengthening local capacities in developing countries to reduce the impact of infectious diseases on vulnerable populations.
[2] In October 2004, the FM was the beneficiary of a Franco-Chinese agreement that led to the creation of the Institut Pasteur de Shanghai and the donation of four truck-trailer BSL-3 laboratories, supplied by Labover.
"[4] In 2015, the CAMS-FM partnership founded the Christophe Mérieux Laboratory (CML) at the Institute of Pathogen Biology in Beijing to focus on the study pneumonia and tuberculosis.
Researchers at the CML "benefit from and training modules developed by the Emerging Pathogens Laboratory in Lyon",[5][6] a BSL-4 lab which was also built by the FM in 1999 and since 2005 is now operated by INSERM.
[10] In July 2020, it was announced that a researcher employed at the CAMS-FM participated in the development of a low-cost COVID-19 screening test, which uses a variant of the CRISPR technology.